▶ 調査レポート

世界のジェネリック腫瘍治療薬市場

• 英文タイトル:Market Study on Generic Oncology Drugs: Market Players to Benefit from Diversification of Product Portfolio

Persistence Market Researchが調査・発行した産業分析レポートです。世界のジェネリック腫瘍治療薬市場 / Market Study on Generic Oncology Drugs: Market Players to Benefit from Diversification of Product Portfolio / PMR2201A065資料のイメージです。• レポートコード:PMR2201A065
• 出版社/出版日:Persistence Market Research / 2021年12月20日
• レポート形態:英文、PDF、176ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥558,600 (USD4,900)▷ お問い合わせ
  Site Licence¥866,400 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,208,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界のジェネリック腫瘍治療薬市場について調査し、エグゼクティブサマリー、市場イントロダクション、市場機会分析、市場背景、北米市場の分析/予測、西ヨーロッパ市場の分析/予測、東ヨーロッパ市場の分析/予測、中南米市場の分析/予測、アジア太平洋市場の分析/予測、中国市場の分析/予測、日本市場の分析/予測、中東・アフリカ市場の分析/予測、関連性/影響、競争分析、地域別分析、分子別(大分子、小分子)分析、投与経路別(経口、非経口)分析、流通チャンネル別(病院薬局、小売薬局、オンライン薬局、管理型医療機関)分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場イントロダクション
・市場機会分析
・市場背景
・北米市場の分析/予測
・西ヨーロッパ市場の分析/予測
・東ヨーロッパ市場の分析/予測
・中南米市場の分析/予測
・アジア太平洋市場の分析/予測
・中国市場の分析/予測
・日本市場の分析/予測
・中東・アフリカ市場の分析/予測
・関連性/影響
・競争分析
・世界のジェネリック腫瘍治療薬市場規模:地域別
・世界のジェネリック腫瘍治療薬市場規模:分子別(大分子、小分子)
・世界のジェネリック腫瘍治療薬市場規模:投与経路別(経口、非経口)
・世界のジェネリック腫瘍治療薬市場規模:流通チャンネル別(病院薬局、小売薬局、オンライン薬局、管理型医療機関)
・仮定
・調査手法

Global Generic Oncology Drugs Market – Report Scope

Persistence Market Research recently published a revised report on the global generic oncology drugs market. The report provides detailed valuation on key market dynamics, such as the drivers, trends, opportunities, and restraints, along with detailed information about the market structure. This research report presents exclusive facts and figures about how the global generic oncology drugs market will grow over the forecast period of 2021 to 2031.

Key indicators of market background, such as value chain analysis and supply chain, compounded annual growth rate (CAGR), and year-on-year (Y-o-Y) growth of the market are explained in Persistence Market Research’s study in a comprehensive manner. This information can help readers understand the quantitative development projections of the generic oncology drugs market over the forecast period.

The study is relevant for stakeholders in the global generic oncology drugs market, as well as manufacturers, distributors, suppliers, and investors, as it can help them understand applicable strategies to grow in the market. Stakeholders, investors, industry experts, researchers, and journalists, as well as business researchers in market can leverage the information and statistics presented in research report.

The report includes facts & figures related to the micro- as well as macro-economic factors that are impacting the growth of the market. The study also offers actionable insights based on the future trends in the market. Furthermore, domestic players and new entrants in the market can also use the information presented in this report to make business decisions and gain momentum in the market.

Key Segments of Market
Persistence Market Research’s study on the global generic oncology drugs market is divided into four significant segments – molecule type, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters related to these categories.

Molecule Type
Large Molecules
Small Molecules

Route of Administration
Oral
Parenteral

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Managed Care Institutions

Region
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excl. China and Japan
China
Japan
MEA

Key Questions Answered in Report
Which region is anticipated to hold a prominent market share over the forecast period?
What will be the key driving factors propelling the demand for generic oncology drugs during the forecast period?
How current trends will impact the global generic oncology drugs industry?
Who are significant market participants in the market?
What are the crucial strategies of prominent players in the global generic oncology drugs market to upscale their positions in this landscape?

Research Methodology
In Persistence Market Research’s research report, exclusive research methodology is utilized to conduct comprehensive research on the development of the global generic oncology drugs market, and reach conclusions on the future growth factors of the market. In this research methodology, secondary and primary research is utilized by analysts to ensure the precision and reliability of the conclusions.

Secondary resources are referred by analysts during the evaluation of the global generic oncology drugs market study, which comprise facts and figures from white papers, trade journals, and external and internal databases. Analysts have thoroughly interviewed several industry experts, such as sales supervisors, sales operation managers, product portfolio managers, senior managers, market intelligence managers, marketing/product managers, engineering managers, and production managers to provide insightful information.

Comprehensive information acquired from primary and secondary resources is validated from companies operating in the global generic oncology drugs market, to make Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.

レポート目次

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition

3. Generic Oncology Drugs Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background

4.1. PESTLE Analysis
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Regulatory Scenario

5. Key Inclusions
5.1. Generic Oncology Drugs Pipeline

6. North America Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
6.4. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
6.4.1. Large Molecule
6.4.2. Small Molecule
6.5. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
6.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
6.6.1. Oral
6.6.2. Parenteral
6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
6.8.1. Hospital Pharmacy
6.8.2. Retail Pharmacy
6.8.3. Online Pharmacy
6.8.4. Managed Care Institutions
6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
6.10. Drivers and Restraints: Impact Analysis
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Molecule Type
6.11.3. By Route of Administration
6.11.4. By Distribution Channel

7. Western Europe Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
7.2.1. Germany
7.2.2. U.K
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Western Europe
7.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
7.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
7.1.1. Large Molecule
7.1.2. Small Molecule
7.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
7.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
7.3.1. Oral
7.3.2. Parenteral
7.4. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
7.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
7.5.1. Hospital Pharmacy
7.5.2. Retail Pharmacy
7.5.3. Online Pharmacy
7.5.4. Managed Care Institutions
7.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
7.7. Drivers and Restraints: Impact Analysis
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Molecule Type
7.8.3. By Route of Administration
7.8.4. By Distribution Channel

8. Eastern Europe Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
8.2.1. Russia
8.2.2. Poland
8.2.3. Rest of Eastern Europe
8.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
8.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
8.1.1. Large Molecule
8.1.2. Small Molecule
8.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
8.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
8.3.1. Oral
8.3.2. Parenteral
8.4. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
8.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
8.5.1. Hospital Pharmacy
8.5.2. Retail Pharmacy
8.5.3. Online Pharmacy
8.5.4. Managed Care Institutions
8.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
8.7. Drivers and Restraints: Impact Analysis
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Molecule Type
8.8.3. By Route of Administration
8.8.4. By Distribution Channel

9. Latin America Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
9.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
9.1.1. Large Molecule
9.1.2. Small Molecule
9.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
9.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
9.3.1. Oral
9.3.2. Parenteral
9.4. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
9.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
9.5.1. Hospital Pharmacy
9.5.2. Retail Pharmacy
9.5.3. Online Pharmacy
9.5.4. Managed Care Institutions
9.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
9.7. Drivers and Restraints: Impact Analysis
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Molecule Type
9.8.3. By Route of Administration
9.8.4. By Distribution Channel

10. Asia Pacific Excluding China & Japan Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
10.2.1. India
10.2.2. Australia and New Zealand
10.2.3. ASEAN
10.2.4. Rest of APECJ
10.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
10.4.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
10.4.1. Large Molecule
10.4.2. Small Molecule
10.5. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
10.6.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
10.6.1. Oral
10.6.2. Parenteral
10.7.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
10.8.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
10.8.1. Hospital Pharmacy
10.8.2. Retail Pharmacy
10.8.3. Online Pharmacy
10.8.4. Managed Care Institutions
10.9.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Molecule Type
10.11.3. By Route of Administration
10.11.4. By Distribution Channel

11. China Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
11.1. Introduction
11.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
11.1.1. Large Molecule
11.1.2. Small Molecule
11.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
11.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
11.3.1. Oral
11.3.2. Parenteral
11.4.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
11.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
11.5.1. Hospital Pharmacy
11.5.2. Retail Pharmacy
11.5.3. Online Pharmacy
11.5.4. Managed Care Institutions
11.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
11.7. Drivers and Restraints: Impact Analysis
11.8. Market Attractiveness Analysis
11.8.1. By Molecule Type
11.8.2. By Route of Administration
11.8.3. By Distribution Channel

12. Japan Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
12.1. Introduction
12.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
12.1.1. Large Molecule
12.1.2. Small Molecule
12.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
12.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
12.3.1. Oral
12.3.2. Parenteral
12.4.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
12.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
12.5.1. Hospital Pharmacy
12.5.2. Retail Pharmacy
12.5.3. Online Pharmacy
12.5.4. Managed Care Institutions
12.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
12.7. Drivers and Restraints: Impact Analysis
12.8. Market Attractiveness Analysis
12.8.1. By Molecule Type
12.8.2. By Route of Administration
12.8.3. By Distribution Channel

13. Middle East and Africa Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of Middle East and Africa
13.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
13.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
13.1.1. Large Molecule
13.1.2. Small Molecule
13.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
13.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
13.3.1. Oral
13.3.2. Parenteral
13.4.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
13.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
13.5.1. Hospital Pharmacy
13.5.2. Retail Pharmacy
13.5.3. Online Pharmacy
13.5.4. Managed Care Institutions
13.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
13.7. Drivers and Restraints: Impact Analysis
13.8. Market Attractiveness Analysis
13.8.1. By Country
13.8.2. By Molecule Type
13.8.3. By Route of Administration
13.8.4. By Distribution Channel

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis
16.1.Competition Dashboard
16.2.Company Deep Dive
16.2.1. Novartis AG
16.2.1.1. Overview
16.2.1.2. Treatment and Application Portfolio
16.2.1.3. Product Footprint
16.2.1.4. Sales Footprint
16.2.1.5. Channel Footprint
16.2.1.6. Strategy
16.2.1.6.1.1 Marketing Strategy
16.2.1.6.1.2. Treatment Strategy
16.2.1.6.1.3. Channel Strategy
16.2.2. Pfizer Inc.
16.2.3. GlaxoSmithKline plc
16.2.4. CELGENE CORPORATION
16.2.5. Teva Pharmaceutical Industries Ltd.
16.2.6. Merck & Company, Inc
16.2.7. Aurobindo Pharma.
16.2.8. Hikma Pharmaceuticals PLC
16.2.9. Mylan N.V.
16.2.10. NATCO Pharma Limited.

17. Global Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031 By Region
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Mn) Analysis By Region
17.2.1. North America
17.2.2. Western Europe
17.2.3. Eastern Europe
17.2.4. Latin America
17.2.5. Asia Pacific Excluding Japan
17.2.6. Japan
17.2.7. China
17.2.8. Middle East and Africa
17.3. Market Size (US$ Mn) Forecast By Region
17.4. Market Attractiveness Analysis By Region

18. Global Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
18.1. Introduction/Key Finding
18.2. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
18.2.1. Large Molecule
18.2.2. Small Molecule
18.3.Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
18.4. Market Attractiveness Analysis By Molecule Type

19. Global Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031, By Route Of Administration
19.1.Introduction/Key Finding
19.2. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2016-2020
19.2.1. Oral
19.2.2. Parenteral
19.3.Market Size (US$ Mn) Forecast By Route Of Administration, 2021-2031
19.4.Market Attractiveness Analysis By Route Of Administration

20. Global Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
20.1.Introduction/Key Finding
20.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
20.2.1. Hospital Pharmacy
20.2.2. Retail Pharmacy
20.2.3. Online Pharmacy
20.2.4. Managed Care Institutions
20.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
20.4.Market Attractiveness Analysis By Distribution Channel

21. Global Generic Oncology Drugs Market Analysis 2016–2020 and Forecast 2021–2031
21.1.Market Value Share Analysis By All Segment
21.2.Y-o-Y Growth Analysis By All Segment
21.3.Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology

List Of Table

Table 01: Generic Oncology Drugs Expected to be Launched by end of 2018
Table 02: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 03: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 04: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 05: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 06: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 07: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 08: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 09: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 10: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 11: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 12: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 13: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 14: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 15: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 16: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 17: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 18: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 19: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 20: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 21: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 22: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 23: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 24: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 25: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 26: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 27: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 28: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 29: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 30: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 31: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel
Table 32: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Region
Table 33: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Molecule Type
Table 34: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Route of Administration
Table 35: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Distribution Channel